Low molecular weight heparins and antithrombotic therapy: results of an audience-interactive symposium.
Marder
V J
VJ
Hematology Unit, University of Rochester, NY 14642, USA.
Hull
R D
RD
D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004581:Electronics; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D009985:Orthopedics; D013923:Thromboembolism / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight